This complimentary activity will provide primary care clinicians with an update on osteoporosis and bone health. Current screening guidelines, modalities, and current prevention & treatment regimens will be highlighted.
Presented by Dr. Paul Doghramji at PCN Destinations, this activity will review the latest guidelines and recommendations on cholesterol management, identify potential cholesterol-lowering therapies beyond statins and know when to utilize and recognize the indications for PCSK9 inhibitor therapy.
Approximately one in three patients have used some form of complementary and integrative medicine (CIM) in the last year. Most do not share their use of unconventional care with their primary care providers. PCPs need to be aware of the prevalence of CIM use in their practice and how it can impact outcomes for better and for worse.
Irritable Bowel Syndrome (IBS) affects 15% of the population. They are a challenging group whose care can often be frustrating. This activity will explain why the diagnosis of IBS in 2020 is no longer a “diagnosis of exclusion”.
In primary care, a sizable number of patients have major depressive disorder (MDD). Of these, up to three quarters are either not treated or incompletely treated. This lack of proper treatment leads to significant reduction in quality of life and carries with it increased risk of morbidity and mortality.
This activity will help the clinician identify common sleep disorders seen in primary care. You will be better able to explain the sleep/wake cycle and circadian rhythms and identify the most appropriate tools used to assess patients’ sleep health.
This migraine activity will focus on issues surrounding diagnosis, management, and current treatment options. These activities were developed from the live migraine conference that took place in Irvine, CA on November 2, 2019.
This activity will assist prescribers in basal insulin initiation and titration in these individuals. We will focus on treatments that allow patients to “self-titrate” their insulin doses while minimizing their risk of hypoglycemia. Barriers to insulin initiation as well as cultural concerns for insulin therapy will be addressed.
This CME activity (recorded from the live webcast held on January 16, 2019) is designed to improve knowledge, attitude and behavior surrounding the awareness, workup and management of geriatric anemia. To accomplish these goals, practical information on differentiating and managing the various causes of geriatric anemia will be presented in an interactive format using real-world clinical cases likely to be seen in primary practice.
Hypoglycemia is the rate limiting step in managing diabetes intensively. Patients who experience treatment emergent hypoglycemia are at increased risk of cardiovascular death and all-cause mortality.